Omnitrope Injection, Solution
Product Images NDC 0781-3001

Product Visual Gallery

This gallery contains 57 technical images submitted to the FDA as part of the official labeling for Omnitrope (NDC 0781-3001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Chemical structure diagram of the amino acid sequence for somatropin, the active ingredient in Omnitrope. The linear peptide chain shows the individual amino acids with disulfide bonds and terminal groups indicated, representing the human growth hormone protein structure.*

FDA Label Image

Fig Aa (Image 02)

An illustrated diagram showing the components and assembly of the Omnitrope Pen 5 injection device by Sandoz Inc. Parts labeled include the cap, outer pen needle shield, inner pen needle shield, pen needle, cartridge holder (with rubber seal and metal cap), cartridge (with plunger and plunger rod), and pen body featuring a dose window, dose dialer, and thumb button. Also shown are a pen injector storage case and an alcohol swab.*

FDA Label Image

Fig Bb (Image 03)

An instructional illustration showing a hand holding an Omnitrope injection pen. The image highlights the pen body and the pen cap, with an arrow indicating the removal of the pen cap from the pen body before use.*

FDA Label Image

Fig Cc (Image 04)

Illustration showing how to attach or insert the Omnitrope cartridge into the holder. It depicts a hand holding the blue cartridge and positioning it into the cartridge holder with arrows indicating the connection steps.*

FDA Label Image

Fig Dd (Image 05)

An instructional illustration showing hands holding a cartridge and inserting it into an injection device. The cartridge is labeled with text pointing to it. This diagram demonstrates part of the preparation or assembly process for an injection device.*

FDA Label Image

Fig Ee (Image 06)

An instructional illustration showing the proper assembly or use of an injection pen for Omnitrope (somatropin). The left panel depicts a hand twisting and pulling the cartridge holder from the pen body, while the right panel details parts of the pen, including a yellow line mark, blue arrow, pen body, and cartridge holder.*

FDA Label Image

Fig Ff (Image 07)

An instructional diagram showing a hand holding a new disposable pen needle with a paper tab, demonstrating how to remove the paper tab from the needle device. The illustration is related to the preparation or use of a pen injection system.*

FDA Label Image

Fig Gg (Image 08)

An instructional illustration showing the attachment of a new disposable pen needle to an injection pen device for subcutaneous administration. The diagram highlights the process of securing the needle onto the pen, with arrows indicating the direction of assembly.*

FDA Label Image

Fig Hh (Image 09)

An instructional line drawing showing hands manipulating a pen-like device, demonstrating how to twist or unlock a cap or component. The arrows indicate rotating motions associated with preparing or using the device, likely related to the subcutaneous injection process.*

FDA Label Image

Fig Ii (Image 10)

An instructional illustration showing a hand removing the outer needle shield from a prefilled injection pen. The pen is held in one hand while the other hand pulls off the protective cover from the needle end, preparing it for a subcutaneous injection.*

FDA Label Image

Fig Jj (Image 11)

An instructional illustration showing a hand holding an injection pen or syringe with the thumb positioned on the plunger, preparing to administer a subcutaneous injection. An arrow indicates a step in the injection process, possibly pressing the plunger to deliver medication.*

FDA Label Image

Fig Kk (Image 12)

Instructional diagram showing the use of an Omnitrope injection pen by Sandoz Inc. It illustrates adjusting the dose knob to set the dose, with a dose window indicating the selected dosage in milligrams. The image demonstrates how to hold the pen for subcutaneous injection.*

FDA Label Image

Fig Ll (Image 13)

An instructional illustration showing a hand holding a syringe with a blue solution, demonstrating the removal of the inner needle shield by pulling it straight off. The image is labeled with arrows indicating the direction to pull and the text 'Inner Needle Shield.' This diagram is related to the preparation of a subcutaneous injection.*

FDA Label Image

Fig Mm (Image 14)

An instructional illustration showing a hand holding a syringe-like injection device labeled with a blue area and a red/white adjustment dial at the bottom. The image depicts rotating the dial, indicated by arrows, as part of preparing the injection device.*

FDA Label Image

Fig Nn (Image 15)

An instructional illustration showing hands manipulating a device, likely a drug injection pen. The thumb and fingers interact with the pen's dial or cap, with circular arrows indicating rotation. An arrow also points to a red mark on the device, suggesting alignment or setup steps.*

FDA Label Image

Fig Oo (Image 16)

Omnitrope 10 mg/1.5 mL injection, solution in a glass vial with a rubber stopper and purple-red cap. The label on the vial shows the brand name Omnitrope, the active ingredient Somatropin, and manufacturer Sandoz Inc. The vial is designed for subcutaneous use and contains 1.5 mL of solution.*

FDA Label Image

Fig Pp (Image 17)

Omnitrope 5 mg/1.5 mL solution for injection, subcutaneous use, in a clear glass vial with a blue and white label. The label includes the product name, strength, and Sandoz Inc as the manufacturer. The vial is designed for human prescription drug use.*

FDA Label Image

Fig Qq (Image 18)

An instructional diagram illustrating how to adjust or unlock a component on a medical injection device. The image shows a hand manipulating a triangular dial or knob on the device, with arrows indicating rotational directions, and a magnified inset highlighting the mechanism, suggesting steps for device operation or preparation for injection.*

FDA Label Image

Fig Rr (Image 19)

An instructional diagram showing recommended subcutaneous injection sites on the human body. Marked injection areas include the abdomen around the navel, outer thighs, and upper buttocks.*

FDA Label Image

Fig Ss (Image 20)

An instructional illustration showing a hand holding a syringe at a 45 to 90-degree angle for subcutaneous injection. The image visually demonstrates proper injection technique, indicating the angle for needle insertion beneath the skin.*

FDA Label Image

Fig Tt (Image 21)

An instructional illustration showing a hand holding an Omnitrope injection pen. Labels point to the dose window and injection button, with an inset timer indicating a 5-second countdown for dose administration. The image visually guides users on how to properly use the injection device for Somatropin injection solution.*

FDA Label Image

Image 22

Instructional diagram showing a hand holding a syringe for subcutaneous injection, with an outer needle shield being removed. Arrows indicate the direction for pulling off the needle shield, demonstrating preparation steps for injection.*

FDA Label Image

Image 23

An instructional illustration showing hands preparing a prefilled injection pen for use. The image depicts a person holding and turning a cap or component of the pen injector, indicating a step in preparing the Omnitrope (somatropin) injection solution for subcutaneous administration.*

FDA Label Image

Image 24

Illustration showing the labeled parts of the Omnitrope Pen 10 injection device by Sandoz Inc. The diagram includes the pen cap, outer and inner pen needle shields, pen needle, cartridge holder with rubber seal and metal cap, cartridge with plunger and rod, pen body with dose window, dose dialer, and thumb button, along with a pen injector storage case and an alcohol swab packet.*

FDA Label Image

Image 25

An instructional illustration showing a hand holding an Omnitrope injection pen with labeled parts, including the pen body and pen cap, demonstrating the removal of the pen cap by pulling it off in the direction indicated by an arrow.*

FDA Label Image

Image 26

An instructional illustration depicting the insertion of a cartridge into a cartridge holder. A hand is shown holding the cartridge and aligning it with the holder for assembly. Circular arrows indicate the motion for inserting or twisting the cartridge into place.*

FDA Label Image

Image 27

An instructional line drawing showing hands holding a syringe-like device labeled as a cartridge, demonstrating how to insert or remove the cartridge from the device. The illustration is likely part of usage instructions for Omnitrope (Somatropin) injection solution.*

FDA Label Image

Image 28

Illustration showing the parts and markings of an Omnitrope injection pen. It highlights the white line mark and blue arrow on the pen body, as well as the cartridge holder. The image includes arrows indicating rotation and movement of components to operate the pen.*

FDA Label Image

Image 29

Instructional illustration showing a hand removing the paper tab from a new disposable pen needle, labeled with parts including 'New Disposable Pen Needle' and 'Paper Tab.' It depicts the proper handling of the pen needle before use.*

FDA Label Image

Image 30

An instructional illustration showing a person attaching a new disposable pen needle to a pen injector device by pushing it on and twisting off the old needle. The image demonstrates proper handling of the pen injector for subcutaneous injection use.*

FDA Label Image

Image 31

An instructional illustration showing hands assembling or preparing an injection device, likely a syringe or pen, by twisting or attaching a needle or component. Arrows indicate the direction of twisting motions. The image relates to a subcutaneous injection procedure.*

FDA Label Image

Image 32

An instructional illustration demonstrating how to remove the outer needle shield from a syringe. The drawing shows a hand gripping the syringe and another hand pulling off the protective outer needle cover.*

FDA Label Image

Image 33

An instructional illustration showing a hand holding a vial or injection device, with an arrow pointing to a part near the top, indicating a step in preparing the injection solution for subcutaneous use.*

FDA Label Image

Image 34

An instructional diagram showing how to set the dose on an Omnitrope injection pen, highlighting the dose knob and dose window with a close-up of the dose window displaying dosage numbers. The image demonstrates adjusting the subcutaneous injection dosage of Omnitrope (somatropin) solution.*

FDA Label Image

Image 35

An instructional diagram showing hands holding a syringe labeled with an inner needle shield. The image demonstrates the removal of the inner needle shield by pulling it straight off the syringe needle, emphasizing safe needle preparation for injection.*

FDA Label Image

Image 36

An instructional illustration showing a hand holding an Omnitrope injection pen. The image depicts twisting or dialing motion at the base of the pen, indicated by circular arrows, demonstrating how to adjust the dose of the injection solution.*

FDA Label Image

Image 37

An instructional illustration showing a person using a pen-type injection device, presumably for Omnitrope (Somatropin) subcutaneous injection. The image depicts the hand adjusting a part of the device with arrows indicating rotational movement, likely for dose setting or preparation.*

FDA Label Image

Image 38

The image shows the packaging of Omnitrope 10 mg/1.5 mL injection solution for subcutaneous use. The carton is primarily white with blue and gray design elements and features the brand name Omnitrope prominently. The label lists Somatropin as the active ingredient and indicates the strength. The labeler is Sandoz Inc.*

FDA Label Image

Image 39

An instructional illustration showing a hand holding an Omnitrope injection pen for subcutaneous use. The inset highlights a dose window indicator displaying '3 mg.' The image depicts adjusting the dose by turning the dial at the pen's base, indicated by curved arrows around it.*

FDA Label Image

Image 40

An illustration showing recommended subcutaneous injection sites for Omnitrope (Somatropin) on the human body. The front view highlights the abdomen and outer thighs, and the back view highlights the buttocks and outer thighs, with blue circles indicating typical injection areas.*

FDA Label Image

Image 41

An instructional illustration showing a hand holding a syringe at a 45 to 90 degree angle, demonstrating the proper technique for subcutaneous injection.*

FDA Label Image

Image 42

An instructional diagram showing a hand holding an Omnitrope injection device. The image highlights the 'Dose Window' and the 'Injection Button,' indicating the user should press the injection button while observing the dose window. A circular timer displays '0' and '5 sec' suggesting a timing element related to the injection process.*

FDA Label Image

Image 43

An instructional illustration demonstrating the removal of the outer needle shield from a syringe containing medication. The labeled arrows indicate the direction to pull the shield away from the syringe before subcutaneous injection.*

FDA Label Image

Image 44

An instructional illustration demonstrating how to use a pen-style injector, showing hands holding the device and preparing for subcutaneous injection. Arrows indicate the twisting motion to adjust or remove the needle cap or prepare the injector for use.*

FDA Label Image

Necessary Items Figure (Image 45)

An instructional line drawing showing the components for reconstitution and subcutaneous injection of Omnitrope (Somatropin) injection solution. It depicts a vial with lyophilized powder, alcohol swabs, vial with diluent, disposable syringes, needle for withdrawing diluent and needle for injection, along with labeled parts of the syringe including needle cap, needle, barrel with dosing scale, and plunger.*

FDA Label Image

Wash Hands Figure (Image 46)

An instructional illustration showing hands being washed under running water from a faucet, with a soap dispenser visible nearby, suggesting hygiene steps before using the medication.*

FDA Label Image

Clean Rubber Top Figure (Image 47)

An instructional illustration showing two steps for preparing an injection vial: the first image depicts removing a cap from the vial, and the second image demonstrates wiping the vial's rubber stopper with an alcohol swab.*

FDA Label Image

Withdraw Diluent Figure (Image 48)

A two-panel instructional illustration showing hands preparing a vial and a syringe. The left panel depicts inserting a syringe needle into a vial rubber stopper. The right panel shows withdrawing solution from the vial into the syringe. The images are instructional for handling injectable medication.*

FDA Label Image

Inject Diluent Figure (Image 49)

An instructional illustration showing a hand holding a vial with a rubber stopper. A syringe needle is inserted through the vial's stopper, indicating the process of drawing medication for injection preparation.*

FDA Label Image

Swirl, Do Not Shake Figure (Image 50)

An instructional illustration showing proper handling of a vial for injection. The left side depicts using one hand to hold the vial and the other hand twisting the cap off. The right side shows a hand holding the vial incorrectly with a cross mark indicating not to hold it vertically by the cap.*

FDA Label Image

Measure The Dose Figure (Image 51)

An instructional line drawing showing a hand holding a vial and drawing liquid from it into a syringe. The image depicts the process of preparing an injection, likely for subcutaneous administration.*

FDA Label Image

Injection Site Figure (Image 52)

An instructional illustration showing recommended subcutaneous injection sites on the human body. Black filled circles indicate preferred injection areas on the abdomen and outer thighs, visible from both front and back views.*

FDA Label Image

Clean Skin Figure (Image 53)

An instructional diagram showing a hand holding the skin of an injection site pinched upward, demonstrating a technique for subcutaneous injection administration, relevant to Omnitrope (somatropin) injection solution.*

FDA Label Image

Insert Needle Figure (Image 54)

An instructional diagram showing the correct angle (45° to 90°) for subcutaneous injection of a solution using a syringe into the skin of a finger or hand.*

FDA Label Image

5 mg/1.5 mL Label (Image 55)

Label for Omnitrope 5 mg/1.5 mL somatropin injection solution for subcutaneous use. The label states it is Rx only and contains one cartridge. The labeler is Sandoz Inc, a Novartis company.*

FDA Label Image

10 mg/1.5 mL Label (Image 56)

Omnitrope Somatropin injection 10 mg/1.5 mL label for subcutaneous injection by Sandoz Inc. The label indicates the product contains one cartridge with 10 mg somatropin per 1.5 mL, intended for prescription use.*

FDA Label Image

5.8 mg Carton (Image 57)

Label of Omnitrope injection, a somatropin solution for subcutaneous use by Sandoz Inc. The label indicates a strength of 5.8 mg per vial and includes 8 vials plus 8 single-use vials of bacteriostatic water diluent. It is marked Rx only and states not for use in newborns.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.